Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
Crossref DOI link: https://doi.org/10.1186/1476-4598-13-158
Published Online: 2014-06-26
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Doloff, Joshua C
Chen, Chong-Sheng
Waxman, David J
Article History
Received: 23 March 2014
Accepted: 16 June 2014
First Online: 26 June 2014